A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex. (Immunity, 2001)

(untitled) - Xu, X; Purbhoo, M; Chen, N; Mongkolsapaya, J; Cox, J; Meier, U; Tafuro, S; Dunbar, P; Sewell, A; Hourigan, C; Appay, V; Cerundolo, V; et al.